The global healthcare 3D printing market size is expected to reach $27,29-billion in 2030 and is projected to grow at a CAGR of 18,5% from 2024 to 2030, according to Grand View Research.

A rising geriatric population and increasing healthcare requirements across the globe have been majorly driving demand.

A rise in the number of orthopaedic and cardiovascular disorders occurring prominently among the aged population have resulted in an increased demand for these printing facilities.

Healthcare 3D printing market provides significant opportunities for manufacturing various medical equipment including dental implants, prosthetic limbs, hearing aids and orthotic footwear.

Government initiatives to develop healthcare infrastructure and rising investments for R&D are some of the factors driving growth.

The ability of the technology to reduce the risks involved with anaesthesia during prolonged surgeries has been another factor resulting in their increasing demand.

Polymers captured over  54,6% of the overall market share in 2023, dominating the raw material segment of the healthcare 3D printing industry. They are primarily used in bio-model printing.

Further highlights from the healthcare 3D printing market report include:

  • eramics are commonly used for manufacturing tooth or mandible (jaw bone). Increasing occurrences of tooth problems including fractures and decays resulting in replacement of crowns or entire teeth is expected to propel demand for biocompatible materials including ceramics.
  • North America accounted for over 38% of the global revenue dominating the regional industry in 2023. Rising awareness among patients, mounting investments for dedicated R&D facilities, advanced healthcare infrastructure coupled with development of 3D printing-based products are expected to drive demand in the region over the forecast period.
  • Rising demand for customised medical equipment and huge investments in R&D programs in Europe are expected to make it the fastest growing market in the next few years. Increasing healthcare investments and expenditures in emerging economies of Asia Pacific are expected to drive demand at a rapid pace over a period of six years.